Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Clinical presentation, treatment patterns, and outcomes of pulmonary embolism in patients with chronic myeloproliferative neoplasms

Published:2023-11 Issue: Volume:231 Page:141-143
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Krečak Ivan,Grohovac Dragana,Vučenović Bašić Nikolina,Čeko Monika,Nižetić Karla,Sabljić Anica,Holik Hrvoje,Galušić Davor,Zekanović Ivan,Morić Perić Martina,Periša Vlatka,Lucijanić Marko

Publisher

Elsevier BV

Subject

Hematology

Reference11 articles.

1. Advances in risk stratification and treatment of polycythemia Vera and Essential thrombocythemia;Krecak;Curr. Hematol. Malig. Rep.,2022

2. Incidence, risk factors and outcomes of pulmonary embolism in Philadelphia negative myeloproliferative neoplasms: a population based study;Gonzalez-Mosquera;Blood,2021

3. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia;Arber;Blood,2016

4. Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism;Jiménez;Arch. Intern. Med.,2010

5. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation;Charlson;J. Chronic Dis.,1987

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. No impact of steatotic liver disease on clinical outcomes in patients with essential thrombocythemia and polycythemia vera: A pilot study;Heliyon;2024-06

2. Prognosis of MPN Patients Experiencing Acute Thrombotic Events and the Potential Role of Cytoreduction;JACC: CardioOncology;2023-12